<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Nephrol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Nephrol</journal-id>
      <journal-title-group>
        <journal-title>BMC Nephrology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2369</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26502965</article-id>
      <article-id pub-id-type="pmc">4624354</article-id>
      <article-id pub-id-type="publisher-id">164</article-id>
      <article-id pub-id-type="doi">10.1186/s12882-015-0164-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Membranoproliferative glomerulonephritis with predominant IgG2 and IgG3 deposition in a patient with IgG4-related disease</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ueki</surname>
            <given-names>Kenji</given-names>
          </name>
          <address>
            <email>ken810@tkz.bbiq.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matsukuma</surname>
            <given-names>Yuta</given-names>
          </name>
          <address>
            <email>ym09045180792@yahoo.co.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Masutani</surname>
            <given-names>Kosuke</given-names>
          </name>
          <address>
            <email>masutani@kcu.med.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsuchimoto</surname>
            <given-names>Akihiro</given-names>
          </name>
          <address>
            <email>tucimoto@intmed2.med.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fujisaki</surname>
            <given-names>Kiichiro</given-names>
          </name>
          <address>
            <email>kiichiro.fujisaki@nifty.ne.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Torisu</surname>
            <given-names>Kumiko</given-names>
          </name>
          <address>
            <email>torisuk@kcu.med.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Shigeru</given-names>
          </name>
          <address>
            <email>sigella1975@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kiyoshima</surname>
            <given-names>Tamotsu</given-names>
          </name>
          <address>
            <email>kiyo@dent.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hisano</surname>
            <given-names>Satoshi</given-names>
          </name>
          <address>
            <email>hisanos1@cis.fukuoka-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kitazono</surname>
            <given-names>Takanari</given-names>
          </name>
          <address>
            <email>kitazono@intmed2.med.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Tsuruya</surname>
            <given-names>Kazuhiko</given-names>
          </name>
          <address>
            <phone>+81-92-642-5843</phone>
            <email>tsuruya@intmed2.med.kyushu-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff4"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan </aff>
        <aff id="Aff2"><label/>Department of Oral Pathology, Graduate School of Dental Sciences, Kyushu University, Fukuoka, Japan </aff>
        <aff id="Aff3"><label/>Department of Pathology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan </aff>
        <aff id="Aff4"><label/>Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>26</day>
        <month>10</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>173</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>5</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Ueki et al. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>IgG4-related disease is a novel disease entity characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. Typical renal pathology is tubulointerstitial nephritis with storiform fibrosis, although the co-existence of various glomerular lesions has been described. Here, we present the first report of a case of IgG4-related kidney disease and membranoproliferative glomerulonephritis showing the discrepancy in IgG subclasses between the kidney interstitium and glomeruli.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 70-year-old Japanese woman was diagnosed with membranoproliferative glomerulonephritis and focal tubulointerstitial nephritis with IgG4-positive plasma cells. Immunofluorescence studies revealed predominant deposition of IgG3 and IgG2, but not IgG4 in the glomeruli. We administered oral prednisolone at 30&#xA0;mg/day, and the abnormalities in urine and blood tests gradually resolved.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>In this case, different patterns of IgG subclasses detected in the glomeruli and interstitial plasma cells suggest overlapping immunologic abnormalities. The favorable clinical course in our patient suggests that steroid therapy is promising in cases of IgG4-related kidney disease accompanied by glomerulonephritis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Corticosteroid</kwd>
        <kwd>Full-house immunofluorescence</kwd>
        <kwd>IgG subclasses</kwd>
        <kwd>Kidney biopsy</kwd>
        <kwd>Salivary gland</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>IgG4-related disease (IgG4-RD) is a novel disease entity characterized by elevated serum IgG4 and tissue infiltration by IgG4-positive plasma cells. Renal involvement is often observed in this disease, and the typical histopathological findings are tubulointerstitial nephritis with abundant IgG4-positive plasma cells and storiform fibrosis and sclerosis [<xref ref-type="bibr" rid="CR1">1</xref>]. With regard to the glomerular lesions, membranous nephropathy is the most common type, and can develop with and without tubulointerstitial nephritis [<xref ref-type="bibr" rid="CR2">2</xref>&#x2013;<xref ref-type="bibr" rid="CR4">4</xref>]. However, some other forms of glomerulonephritis, such as mesangial proliferative glomerulonephritis, IgA nephropathy, Henoch&#x2013;Sch&#xF6;nlein purpura nephritis (IgA vasculitis), endocapillary proliferative glomerulonephritis, and membranoproliferative glomerulonephritis (MPGN) have also been reported [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. In the cases with membranous nephropathy, IgG4 deposition along the glomerular capillaries was demonstrated [<xref ref-type="bibr" rid="CR8">8</xref>], suggesting that membranous nephropathy shares the same pathogenesis as systemic serological abnormalities and other types of organ involvement. However, the interpretation of the pathogenesis of other types of glomerulonephritis is still unclear.</p>
      <p>Here, we report the case of a patient diagnosed with IgG4-RD, complicated with MPGN and accompanied by focal tubulointerstitial nephritis with IgG4-positive plasma cells. We also investigated IgG subclasses in the glomeruli, and found predominant deposition of IgG3 and IgG2, but not IgG4.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 70-year-old Japanese woman with a past history of bronchial asthma and paroxysmal atrial fibrillation was transferred to Kyushu University Hospital because of leg edema and insidious onset of proteinuria and microhematuria. She had presented with mild leg edema 8&#xA0;months before, and was admitted to another hospital because of pneumonia. Then heavy proteinuria was identified. She had a history of polyarthralgia, although other symptoms such as skin rash, hair loss, oral ulcers, and Sicca syndrome were not evident.</p>
      <p>On admission, the patient&#x2019;s characteristics were: height 144&#xA0;cm, body weight 38.7&#xA0;kg, body temperature 36.9&#xA0;&#xB0;C, and blood pressure 120/46&#xA0;mmHg. Physical examination revealed normal breath sounds, heart sounds, abdomen and nervous system, but signs of anemia in the palpebral conjunctiva and bilateral leg edema were found. Urinalysis revealed proteinuria (2+), and occult blood (2+). Urinary protein excretion was 2.3&#xA0;g/day. Complete blood counts revealed: white blood cells 3050/&#x3BC;L, red blood cells 252&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L, hemoglobin 8.2&#xA0;g/dL, hematocrit 24.3&#xA0;%, and platelets, 12.9&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L, with no atypical leukocytes. Serum biochemical analyses revealed: total protein 6.9&#xA0;g/dL, serum albumin 3.0&#xA0;g/dL, blood urea nitrogen 33.0&#xA0;mg/dL, serum creatinine 1.09&#xA0;mg/dL (eGFR 43.2&#xA0;mL/min/1.73&#xA0;m<sup>2</sup>), sodium 141&#xA0;mmol/L, potassium 5.1&#xA0;mmol/L, chloride 115&#xA0;mmol/L, calcium 8.3&#xA0;mg/dL, phosphate 4.9&#xA0;mg/dL, and C-reactive protein 0.21&#xA0;mg/dL. Quantitative immunoglobulin analysis showed: IgG 2407&#xA0;mg/dL (normal, 872&#x2013;1815&#xA0;mg/dL), IgA 114&#xA0;mg/dL and IgM 53&#xA0;mg/dL (59&#x2013;269&#xA0;mg/dL), and the additional measurement of IgG subclasses revealed IgG1 564&#xA0;mg/dL (320&#x2013;748&#xA0;mg/dL), IgG2 1650&#xA0;mg/dL (208&#x2013;754&#xA0;mg/dL), IgG3 214&#xA0;mg/dL (6.6-88.3&#xA0;mg/dL), and IgG4 1110&#xA0;mg/dL (4.8&#x2013;105&#xA0;mg/dL). Serum levels of C3, C4 and total serum hemolytic activity (CH<sub>50</sub>) were 58&#xA0;mg/dL (71&#x2013;135&#xA0;mg/dL), 9&#xA0;mg/dL (11&#x2013;34&#xA0;mg/dL), and 32 U/mL (31.6&#x2013;57.6 U/mL), respectively. Although rheumatoid factor was increased to 133&#xA0;IU/mL (&lt;15&#xA0;IU/mL), antinuclear antibodies, anti-double-stranded DNA antibodies, anti-U1-ribonucleoprotein antibodies, myeloperoxidase anti-neutrophil cytoplasmic antibodies (ANCA), proteinase 3 ANCA, anti-glomerular basement membrane (GBM) antibodies, anti-Sj&#xF6;gren syndrome related antigen (SS)-A antibodies, anti-SS-B antibodies, circulating immune complexes, and cryoglobulins were all negative. Hepatitis B virus surface antigen, hepatitis C virus antibodies, and human T-lymphotropic virus 1 antibodies were negative. T-SPOT.TB assays for the diagnosis of latent tuberculosis was also negative. Abdominal ultrasonography and computed tomography scanning revealed the absence of systemic lymphadenopathy, and no abnormal findings in the pancreas, salivary glands, and thyroid gland, although ultrasonography showed mild enlargement of bilateral kidneys (right 10.3&#x2009;&#xD7;&#x2009;4.4&#xA0;cm, and left 10.8&#x2009;&#xD7;&#x2009;4.1&#xA0;cm).</p>
      <p>Percutaneous kidney biopsy was performed on the 12th hospital day to determine the cause of the urinary abnormalities and kidney dysfunction. Light microscopic observation revealed global glomerulosclerosis in 1 of 13 glomeruli with mild interstitial edema and inflammation (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). The infiltrating cells were mainly mononuclear cells, but occasional eosinophils and a number of plasma cells were also noted. Storiform interstitial fibrosis was not evident (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). Twelve non-sclerotic glomeruli showed uniform changes; moderate to severe mesangial proliferation, increased mesangial matrix, and mild to moderate endocapillary hypercellularity. Subendothelial deposits (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>), and double contours of the glomerular capillaries were also observed (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). No glomerular crescent was found. Immunofluorescence studies showed &#x201C;full-house&#x201D; staining for IgG (3+), IgA (1+), IgM (1+), C3 (2+), C1q (3+), and fibrinogen (1+) in the glomerular mesangium and the capillary wall (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). Ultrastructural examination showed focal foot process effacement of the glomerular epithelial cells, mesangial and subendothelial electron-dense deposits, and mesangial interposition (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). According to these findings, we confirmed the pathological diagnosis of MPGN type 1.<fig id="Fig1"><label>Fig. 1</label><caption><p>Light microscopic findings of kidney biopsy. <bold>a</bold> Kidney tissue showing focal interstitial inflammation and edema without evident storiform fibrosis. Hematoxylin and eosin (H&amp;E) staining (magnification, &#xD7; 100). <bold>b</bold> Interstitial infiltrating cells dominated by mononuclear cells, although infiltrating eosinophils and plasma cells are also observed. H&amp;E staining (magnification, &#xD7; 400). <bold>c</bold> Glomerulus showing mesangial proliferation, endocapillary hypercellularity, and subendothelial deposits. Periodic acid Schiff staining (magnification, &#xD7; 400). <bold>d</bold> Double contours of glomerular capillaries are frequently observed. Periodic acid silver methenamine staining, (magnification, &#xD7; 400)</p></caption><graphic xlink:href="12882_2015_164_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Immunofluorescence staining for immunoglobulin and complement. Glomerular depositions of IgG (3+), IgA (1+), IgM (1+), C3 (2+), C1q (3+) and fibrinogen (1+) are evident in the mesangial area and capillary loop</p></caption><graphic xlink:href="12882_2015_164_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Electron microscopic findings. <bold>a</bold> Mesangial cell proliferation, mesangial matrix increase and mesangial electron dense deposit, and mesangial interposition (<italic>arrow</italic>) are noted. Subepithelial deposits were not found in the sampled glomeruli. <bold>b</bold> Diffuse foot process effacement and subendothelial electron dense deposit (<italic>arrowhead</italic>) are noted</p></caption><graphic xlink:href="12882_2015_164_Fig3_HTML" id="MO3"/></fig></p>
      <p>Because the patient showed extremely high serum IgG4, we performed a lip biopsy and found the diffuse infiltration of IgG4 positive plasma cell in the glandular area (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a and b</xref>); thus, the diagnosis of IgG4-RD was confirmed. Kidney-infiltrating plasma cells also produced IgG4, suggesting focal and early stage IgG4-related kidney disease (IgG4-RKD) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4c and d</xref>). However, additional immunofluorescence studies revealed predominant deposition of IgG2 and IgG3, negative IgG1, and minimal IgG4 deposition in the glomeruli (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4e&#x2013;h</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Immunohistochemical staining for IgG4 in lip and kidney biopsies. <bold>a</bold> Immunohistochemical staining for CD138 in a lip biopsy specimen. <bold>b</bold> IgG4 staining in the lip using serial section. In the glandular area, diffuse infiltration of IgG4-positive plasma cells is observed, and an IgG4/CD138 ratio is approximately 85&#xA0;%. <bold>c</bold> Immunohistochemical staining for IgG in a kidney biopsy specimen. <bold>d</bold> IgG4 staining in the kidney using serial section revealed several foci of IgG4-positive cells in the interstitium. The IgG4/IgG ratio is approximately 90&#xA0;%. Original magnification, &#xD7; 400. <bold>e</bold>&#x2013;<bold>h</bold> Glomeruli showing predominant IgG2 and IgG3 (IgG3&#x2009;&gt;&#x2009;IgG2) deposition in the mesangial area and capillary loop. Deposition of IgG1 is negative, and IgG4 shows weak and segmental deposition</p></caption><graphic xlink:href="12882_2015_164_Fig4_HTML" id="MO4"/></fig></p>
      <p>Although we found discrepancies in IgG subclass among the glomeruli and kidney interstitium, we treated this patient as IgG4-RD. Oral prednisolone administration (initial dose 30&#xA0;mg/day) was started. The patient showed decreased urinary protein, and increased serum albumin and complement levels. In examinations conducted in our outpatient clinic 8&#xA0;months later, the patient showed proteinuria (&#xB1;), hematuria (3+), white blood cell count 9690/&#x3BC;L, hemoglobin 11.4&#xA0;g/dL, platelet count 32.5&#x2009;&#xD7;&#x2009;10<sup>4</sup>/&#x3BC;L, serum albumin 3.9&#xA0;g/dL, serum creatinine 0.96&#xA0;mg/dL, C3 99&#xA0;mg/dL, C4 23&#xA0;mg/dL, IgG 1002&#xA0;mg/dL and IgG4 200&#xA0;mg/dL (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><p>Clinical course of this patient. Up/UCr; urinary protein/creatinine ratio, Bx; biopsy</p></caption><graphic xlink:href="12882_2015_164_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Here, we report the case of a patient diagnosed as IgG4-RD accompanied by MPGN type 1 with &#x201C;full-house immunofluorescence&#x201D;. We confirmed the diagnosis of IgG4-RD with serological tests and a lip biopsy showing significant infiltration of the glandular area by IgG4-positive plasma cells. IgG4-positive plasma cells with little fibrosis were also found in the kidney interstitium, and the IgG4/IgG ratio exceeded 40&#xA0;%. We then diagnosed IgG4-RKD equivalent to stage A tubulointerstitial nephritis according to the schema suggested by Yamaguchi et al. [<xref ref-type="bibr" rid="CR9">9</xref>]. However, the predominant IgG2/IgG3 deposition and minimal IgG4 deposition in the glomeruli conflicted with the systemic serological status, and the pathology of minor salivary glands and kidney interstitium. In this case, the most important differential diagnosis was a proliferative form of lupus nephritis because the patient developed hypocomplementemia and pancytopenia. However, her extrarenal symptoms did not suggest systemic lupus erythematosus (SLE), and laboratory data revealed that she was negative for antinuclear antibodies and anti-DNA antibodies; thus, ultimately, the patient did not fulfill the criteria of SLE.</p>
      <p>Renal involvement in IgG4-RD, designated IgG4-RKD, is characterized by increased IgG4-positive plasma cells in the kidney interstitium, and various degrees of storiform fibrosis that can be recognized with methenamine silver and trichrome stains. Several forms of concurrent glomerulonephritis have been reported in IgG4-RKD [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. Membranous nephropathy is the most common, and predominant IgG4 deposition along the glomerular capillary has been demonstrated [<xref ref-type="bibr" rid="CR8">8</xref>], suggesting a common pathophysiology with systemic IgG4 overexpression and related cytokine production. However, in patients with IgG4-RD with other forms of glomerulonephritis, the common pathophysiology between systemic abnormalities and glomerular lesions is less apparent. One case of IgG4-RD and MPGN has been reported previously, but unfortunately, immunofluorescence analysis of IgG subclasses in the glomeruli was not included [<xref ref-type="bibr" rid="CR5">5</xref>]. Thus, this is the first report of a case of IgG4-RKD and MPGN showing the discrepancy in IgG subclasses between the kidney interstitium and glomeruli.</p>
      <p>The immunological abnormalities associated with IgG4-RD have been extensively investigated, and recent studies suggest an important role of T-helper (Th) 2 cells and regulatory T cells (Treg) in the development of IgG4-RD. M&#xFC;ller et al. demonstrated increased interleukin (IL)-4 and IL-5 levels, and upregulated IL-13 mRNA in bile samples from a patient with IgG4-related cholangitis [<xref ref-type="bibr" rid="CR10">10</xref>]. Tanaka et al. investigated the expression patterns of cytokines, chemokines, and cytokine receptors in the labial salivary glands of patients with Mikulicz disease and Sj&#xF6;gren syndrome, and demonstrated that mRNA levels of IL-4, IL-5, IL-10, TGF-&#x3B2;, and Foxp3 were upregulated in Mikulicz disease compared with Sj&#xF6;gren syndrome and controls [<xref ref-type="bibr" rid="CR11">11</xref>]. In the present case, predominant deposition of IgG2 and IgG3, but not IgG4 was found in the glomeruli, and immunofluorescence analysis showed that IgG3 deposition predominated. IgG3 is well-known as the typical &#x201C;Th1 subclass IgG&#x201D; and associated with primary MPGN [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In general, Th1 and Th2 cells suppress each other, and polarization toward a Th1 nephritogenic immune response is associated with proliferative, crescentic forms of glomerulonephritis such as MPGN, ANCA-associated glomerulonephritis, and anti-GBM antibody glomerulonephritis, whereas Th2 activation is found in membranous nephropathy [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The renal pathology of the present case revealed co-existence of a Th1-associated pro-inflammatory response in the glomeruli, and Th2/Treg-associated changes in the interstitium. Similar phenomena of overlapping different pathologies can be found in the exceptional cases of crescentic membranous nephropathy with or without ANCA [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Furthermore, in lupus nephritis, co-incidence of class IV and class V glomerular lesions are often found [<xref ref-type="bibr" rid="CR18">18</xref>]. Further investigations are required to clarify the detailed mechanisms of the co-existence of two different immune responses in the same patient.</p>
      <p>With regard to the treatment, we initially started low-dose oral prednisolone (30&#xA0;mg/day) which was previously reported for the treatment of IgG4-RKD [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], after we had carefully excluded SLE, cryoglobulinemic vasculitis, and monoclonal immunoglobulin deposition disease. Although low-dose steroid monotherapy is not sufficient for primary MPGN type 1, the patient&#x2019;s urinary protein immediately decreased, kidney function was preserved, and serum IgG4 levels showed a gradual decline. The complement levels and complete blood cell counts also returned to the normal range. In the previous report of MPGN and IgG4-RKD reported by Morimoto et al. [<xref ref-type="bibr" rid="CR5">5</xref>], the patient died of mycoplasma pneumonia and congestive heart failure a few months after the biopsy confirmation and without receiving corticosteroids. Thus, the favorable clinical course in our case is promising, and it is important to collect information on more cases of IgG4-RKD accompanied by glomerulonephritis to determine the response of such patients to steroid therapy.</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>We have described the case of a patient with IgG4-RD accompanied by IgG4-related tubulointerstitial nephritis and MPGN with predominant IgG2 and IgG3 deposition. Different patterns of IgG subclasses detected in the glomeruli and interstitial plasma cells suggest overlapping immunologic abnormalities. IgG4-RD is a novel disease entity and the detailed pathophysiology is still unknown; thus, this emphasizes the need to accumulate the details of more cases of IgG4-RKD, and perform IgG subclass staining extensively if glomerular lesions are found in IgG4-RKDs to clarify the nature of this disease.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>ANCA</term>
          <def>
            <p>Anti-neutrophil cytoplasmic antibodies</p>
          </def>
        </def-item>
        <def-item>
          <term>IgG4-RD</term>
          <def>
            <p>IgG4-related disease</p>
          </def>
        </def-item>
        <def-item>
          <term>IgG4-RKD</term>
          <def>
            <p>IgG4-related kidney disease</p>
          </def>
        </def-item>
        <def-item>
          <term>IL</term>
          <def>
            <p>Interleukin</p>
          </def>
        </def-item>
        <def-item>
          <term>MPGN</term>
          <def>
            <p>Membranoproliferative glomerulonephritis</p>
          </def>
        </def-item>
        <def-item>
          <term>SLE</term>
          <def>
            <p>Systemic lupus erythematosus</p>
          </def>
        </def-item>
        <def-item>
          <term>SS</term>
          <def>
            <p>Anti-Sj&#xF6;gren syndrome related antigen</p>
          </def>
        </def-item>
        <def-item>
          <term>Th</term>
          <def>
            <p>T-helper</p>
          </def>
        </def-item>
        <def-item>
          <term>Treg</term>
          <def>
            <p>Regulatory T cells</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>Honoraria: Takanari Kitazono (Bayer Pharmaceutical Co., Bristol-Myers Squibb Co., Daiichi-Sankyo Co.), Kazuhiko Tsuruya (Chugai Pharmaceutical Co., Kyowa Hakko Kirin Co.).</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>KU was in charge of the patient&#x2019;s treatment and care in hospital and drafted the manuscript. YM performed diagnosis of renal biopsy and drafted the manuscript. KM and ST were involved in the diagnostic procedures and in critically revising the manuscript for intellectual content. AT was in charge of the diagnosis of renal biopsy and outpatient treatment. KF and K. Torisu helped in drafting the manuscript. T. Kiyoshima diagnosed the patient&#x2019;s lip biopsy. SH provided significant advice of renal biopsy. T. Kitazono critically revised the manuscript. K. Tsuruya supervised the management of patient and revised the final manuscript for submission. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Ms. Hideko Noguchi for her excellent technical assistance.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>Takanari Kitazono (Astellas Pharma Inc., Daiichi-Sankyo Co., Eisai Co., Kyowa Hakko Kirin Co., Mitsubishi Tanabe Pharma Co., MSD K.K., Ono Pharmaceutical Co., Otsuka Pharmaceutical Co., Sanofi-Aventis Pharmaceutical Co., Takeda Pharmaceutical Co.), Kazuhiko Tsuruya (Chugai Pharmaceutical Co., Kyowa Hakko Kirin Co., Otsuka Pharmaceutical Co., Takeda Pharmaceutical Co.). Endowed department: Kazuhiko Tsuruya (Baxter).</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umehara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011</article-title>
          <source>Mod Rheumatol</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>21</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.3109/s10165-011-0571-z</pub-id>
          <pub-id pub-id-type="pmid">22218969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>IW</given-names>
            </name>
            <name>
              <surname>Nasr</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Sethi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fidler</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Membranous glomerulonephritis is a manifestation of IgG4-related disease</article-title>
          <source>Kidney Int</source>
          <year>2013</year>
          <volume>83</volume>
          <fpage>455</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2012.382</pub-id>
          <pub-id pub-id-type="pmid">23254897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related renal disease</article-title>
          <source>Kidney Int</source>
          <year>2014</year>
          <volume>85</volume>
          <fpage>251</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2013.393</pub-id>
          <pub-id pub-id-type="pmid">24107849</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathological findings of immunoglobulin G4-related kidney disease</article-title>
          <source>Clin Exp Nephrol</source>
          <year>2011</year>
          <volume>15</volume>
          <fpage>810</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1007/s10157-011-0526-x</pub-id>
          <pub-id pub-id-type="pmid">21870078</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morimoto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fukushima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Uesugi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hisano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis</article-title>
          <source>Intern Med</source>
          <year>2009</year>
          <volume>48</volume>
          <fpage>157</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.2169/internalmedicine.48.1339</pub-id>
          <pub-id pub-id-type="pmid">19182426</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hayatsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of gG4</article-title>
          <source>Clin Nephrol</source>
          <year>2007</year>
          <volume>68</volume>
          <fpage>308</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.5414/CNP68308</pub-id>
          <pub-id pub-id-type="pmid">18044263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mizushima</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Aizu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mizutomi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Henoch&#x2013;Sch&#xF6;nlein purpura nephritis in a patient with IgG4-related renal disease: A possible association</article-title>
          <source>Clin Nephrol</source>
          <year>2013</year>
          <volume>79</volume>
          <fpage>246</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.5414/CN107114</pub-id>
          <pub-id pub-id-type="pmid">22841022</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nishi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imai</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis</article-title>
          <source>Kidney Int</source>
          <year>2010</year>
          <volume>78</volume>
          <fpage>1016</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.2010.271</pub-id>
          <pub-id pub-id-type="pmid">20720530</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamaguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kanetsuna</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamanaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characteristic tubulointerstitial nephritis in IgG4-related disease</article-title>
          <source>Hum Pathol</source>
          <year>2012</year>
          <volume>43</volume>
          <fpage>536</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2011.06.002</pub-id>
          <pub-id pub-id-type="pmid">21889187</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Beutler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pic&#xF3;</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Otten</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>D&#xFC;rr</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Al-Abadi</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-Associated biliary epithelial cell barrier</article-title>
          <source>Gastroenterology</source>
          <year>2013</year>
          <volume>144</volume>
          <fpage>1116</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1053/j.gastro.2013.01.055</pub-id>
          <pub-id pub-id-type="pmid">23391819</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Moriyama</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miyake</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hayashida</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Maehara</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease</article-title>
          <source>Arthritis Rheum</source>
          <year>2012</year>
          <volume>64</volume>
          <fpage>254</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1002/art.33320</pub-id>
          <pub-id pub-id-type="pmid">21898360</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tipping</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Holdsworth</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>T cells in glomerulonephritis</article-title>
          <source>Springer Semin Immunopathol</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>377</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1007/s00281-003-0121-7</pub-id>
          <pub-id pub-id-type="pmid">12778334</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Imai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hmai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Komatsuda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ohtani</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mura</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis</article-title>
          <source>Kidney Int</source>
          <year>1997</year>
          <volume>51</volume>
          <fpage>270</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1038/ki.1997.32</pub-id>
          <pub-id pub-id-type="pmid">8995742</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masutani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tokumoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tsuruya</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kashiwagi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kudoh</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis</article-title>
          <source>Clin Nephrol</source>
          <year>2003</year>
          <volume>59</volume>
          <fpage>395</fpage>
          <lpage>405</lpage>
          <pub-id pub-id-type="doi">10.5414/CNP59395</pub-id>
          <pub-id pub-id-type="pmid">12834170</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masutani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nakashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yotsueda</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kudoh</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsuruya</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Up-regulated interleukin-4 production by peripheral t-helper cells in idiopathic membranous nephropathy</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>580</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1093/ndt/gfg572</pub-id>
          <pub-id pub-id-type="pmid">14767012</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Nasr</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Sethi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fidler</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Cornell</surname>
              <given-names>LD</given-names>
            </name>
          </person-group>
          <article-title>Membranous nephropathy with crescents: a series of 19 cases</article-title>
          <source>Am J Kidney Dis</source>
          <year>2014</year>
          <volume>64</volume>
          <fpage>66</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2014.02.018</pub-id>
          <pub-id pub-id-type="pmid">24709471</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Narita</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shimaya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy</article-title>
          <source>BMC Nephrol</source>
          <year>2013</year>
          <volume>14</volume>
          <fpage>73</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2369-14-73</pub-id>
          <pub-id pub-id-type="pmid">23537120</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chino</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Matsumoto</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis</article-title>
          <source>Clin Exp Immunol</source>
          <year>2009</year>
          <volume>159</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.04031.x</pub-id>
          <pub-id pub-id-type="pmid">19807734</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
